Cargando…
Clinical Trials Supporting the Role of the IL-17/IL-23 Axis in Axial Spondyloarthritis
The term spondyloarthritis (SpA) encompasses a heterogeneous group of inflammatory musculoskeletal diseases with several common genetic background and clinical features, including the possible involvement of the axial skeleton with peripheral mono- or oligo- arthritis and frequently coexisting skin,...
Autores principales: | Ceribelli, Angela, Motta, Francesca, Vecellio, Matteo, Isailovic, Natasa, Ciccia, Francesco, Selmi, Carlo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8206811/ https://www.ncbi.nlm.nih.gov/pubmed/34149686 http://dx.doi.org/10.3389/fimmu.2021.622770 |
Ejemplares similares
-
The IL-17/IL-23 Axis and Its Genetic Contribution to Psoriatic Arthritis
por: Vecellio, Matteo, et al.
Publicado: (2021) -
Anti-IL-17 Agents in the Treatment of Axial Spondyloarthritis
por: Atzeni, Fabiola, et al.
Publicado: (2021) -
The Role of the IL-23/IL-17 Pathway in the Pathogenesis of Spondyloarthritis
por: Tsukazaki, Hiroyuki, et al.
Publicado: (2020) -
Antigen Reactivity and Clinical Significance of Autoantibodies Directed Against the Pyruvate Dehydrogenase Antigen Complex in Patients With Connective Tissue Disease
por: Ceribelli, Angela, et al.
Publicado: (2022) -
No Significant Effects of IL-23 on Initiating and Perpetuating the Axial Spondyloarthritis: The Reasons for the Failure of IL-23 Inhibitors
por: Zhang, Hua, et al.
Publicado: (2022)